SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 30, 17:00
3098.10
51.75 (1.7%)
VOLUME 15,804
LIVE
NSE
Oct 30, 17:00
3094.90
49.3 (1.62%)
VOLUME 486,562
News on Dr Reddys Laboratories
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Stocks in news: Maruti, Bharti, ICICI, Tech Mahindra, SBBJ

8.27 am | 30 Oct 2014 |  Source: CNBC-TV18

Maruti Suzuki | Bharti Airtel | ICICI Bank | Tech Mahindra | Dr Reddy's Labs | Sesa Sterlite | Container Corporation | Gati | Raymond | State Bank Of ...

Market momentum to continue in near term: Experts 

5.34 pm | 29 Oct 2014 |  Source: CNBC-TV18

Shares continued their uptrend today with both Sensex and Nifty rising 0.8 percent each. The outlook for the markets both from technical and fundament...

Likely to file 2 NDAs worth $100 m each soon: Dr Reddy's 

4.51 pm | 29 Oct 2014 |  Source: CNBC-TV18

Discussing the company’s results, GV Prasad co-chairman and CEO, DRL, said the quarter has been a flattish one on the back of high R&D expenses. He ...

Accumulate Dr Reddy's Laboratories: Phani Sekhar 

4.29 pm | 29 Oct 2014 |  Source: CNBC-TV18

Phani Sekhar of Angel Broking recommends accumulating Dr Reddy's Laboratories for long term....

Dr Reddy's Q2: Revenue hit by high expenditure, says expert 

1.21 pm | 29 Oct 2014 |  Source: CNBC-TV18

Dr Reddy's Laboratories reported a fall of 16.8 percent in its second quarter consolidated net profit to Rs 574 crore against Rs 690.2 crore in the ye...

Dr Reddy's Labs Q2 disappoints, net falls 17% to Rs 574 cr 

12.39 pm | 29 Oct 2014 |  Source: Moneycontrol.com

Consolidated operating profit during the quarter declined 12.2 percent year-on-year to Rs 646.5 crore and margin dropped 400 basis points to 18 percen...

US core business continues to be a drag for Ranbaxy: CIMB 

9.05 am | 29 Oct 2014 |  Source: CNBC-TV18

Prakash Agarwal, Equity Analyst, CIMB has a hold rating on Ranbaxy with target price of Rs 630/share. ...

Stocks in news: Hero, Dr Reddy's Labs, ONGC, BHEL, SRF, SBT

8.28 am | 29 Oct 2014 |  Source: CNBC-TV18

Hero Motocorp | State Bank of India | Dr Reddy's Labs | ONGC | BHEL | Ranbaxy Labs | Jubilant Life | ING Vysya Bank | SRF | CCL Products | PI Industri...

10-sec guide to cues that will affect trade today

7.56 am | 29 Oct 2014 |  Source: Moneycontrol.com

US markets gained with the Dow closing above the 17,000 levels. Europe too ended firmly higher while Asia tracks wall street gains with Japan's Nikkei...

Dr Reddy's Labs Q2 profit may fall 22% to Rs 537 cr: Poll

5.16 pm | 28 Oct 2014 |  Source: CNBC-TV18

Revenue is likely to increase 10.3 percent to Rs 3,702 crore in the quarter ended September 2014 compared to Rs 3,357 crore in same quarter last year ...

Buy Dr Reddys Lab, Glenmark Pharma: Sukhani 

10.21 am | 27 Oct 2014 |  Source: CNBC-TV18

According to Sudarshan Sukhani of s2analytics.com, one may buy Dr Reddys Laboratories and Glenmark Pharma....

Bank Nifty may remain choppy, avoid for short-term: Sukhani 

9.57 am | 27 Oct 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics feels the focus should be on the Nifty, on some sectors, IT, pharmaceutical, oil and gas – they could take the Nift...

Super Six stocks you can bet on October 22 

9.11 am | 22 Oct 2014 |  Source: CNBC-TV18

Manas Jaiswal of manasjaiswal.com recommends buying IRB Infra with a target of Rs 254 and NHPC with a target of Rs 21....

Nifty likely to consolidate in 7800-8200 range: ICICIdirect

3.18 pm | 14 Oct 2014 |  Source: Moneycontrol.com

According to ICICIdirect.com Nifty is likely to continue consolidation in range of 7800-8200. One can sell 1 lot of Nifty October 7900 Put in the rang...

Here's why pharma sector will continue outperforming

2.53 pm | 11 Oct 2014 |  Source: Moneycontrol.com

Analysts at Motilal Oswal believe that Lupin, Ranbaxy, Cadila Healthcare, GSK Pharma, Torrent Pharma and Alembic Pharma will report stronger overall o...

Krish Subramanyam advises bull spread in Dr Reddy's Labs 

1.42 pm | 09 Oct 2014 |  Source: CNBC-TV18

Krish Subramanyam of Asit C Mehta Inv Intermediates recommends bull spread in Dr Reddy's Laboratories wherein one can buy 3000 call and sell 3200 call...

Here are Krish Subramanyam's top trading ideas 

1.37 pm | 09 Oct 2014 |  Source: CNBC-TV18

Watch the interview of Krish Subramanyam, Asit C Mehta Inv Intermediattes with Ekta Batra & Anuj Singhal on CNBC-TV18, in which he shared his readings...

Why action is unlikely in US generics pricing probe

1.12 pm | 09 Oct 2014 |  Source: Moneycontrol.com

A JM financial probe said that the probability of any major action against generic pharma companies accused of inflating generic drug prices is low be...

Top 10 stocks to keep an eye on October 9 

8.38 am | 09 Oct 2014 |  Source: CNBC-TV18

Here are Top 10 stocks to focus on October 9 - Ashok Leyland, Zee Entertainment, Sun Pharma, Dr Reddy's, Hindustan Zinc, Hindalco, BHEL, Polaris, Maha...

Market cues to give you a head start on Thursday

7.51 am | 09 Oct 2014 |  Source: Moneycontrol.com

Global equities traded mixed as US markets extended gains post the FOMC minutes closing up nearly 2 percent, Europe ended lower on growth fears. Asian...

1 2 3 4 5 6
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.